SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Neoimmunetech to Brief Investors on R&D Developments

Neoimmunetech plans to hold a briefing for securities analysts and institutional investors in Seoul on Nov. 4–5, 2026, to discuss its research and development status.

Related stories